Comment from Emergency Medicine Residents' Association

Submitted Electronically Acting Commissioner of Food and Drugs, Kyle A. Diamantas, J.D. U.S. Food and Drug Administration 10903 New Hampshire Ave. Silver Spring, MD 20993 Comment of Emergency Medicine Residents’ Association in Support of Citizen Petitions FDA-2025-P-0377-0001; FDA-2025-P-0377-0250; FDA-2025-P-1576-0001; FDA-2025-P-3287-0001; and FDA-2025-P-2162-0001 The Emergency Medicine Residents’ Association (“EMRA”) submit this comment in full support of the Citizen Petitions filed by the American College of Obstetricians and Gynecologists ("ACOG"), the Society of Family Planning, and the Society for Maternal-Fetal Medicine (FDA-2025-P-0377-0001) and the ACOG Supplemental Citizen Petition (FDA-2025-P-0377-0250); the Commonwealth of Massachusetts, along with the states of California, New Jersey, and New York (FDA-2025-P-1576-0001); the states of Washington, Arizona, Colorado, Connecticut, Delaware, Hawai’i, Illinois, Maine, Maryland, Michigan, Minnesota, Nevada, New Mexico, Oregon, Rhode Island, the District of Columbia, and Josh Shapiro in his official capacity as Governor of the Commonwealth of Pennsylvania (FDA-2025-P-3287-0001); and GenBioPro, Inc. (FDA-2025-P-2162-0001) (collectively “Petitioners”) regarding the U.S. Food and Drug Administration's ("FDA") regulation of mifepristone. EMRA supports Petitioners' request that FDA: (1) remove the Mifepristone Shared System Risk Evaluation and Mitigation Strategy ("REMS"), including all of its Elements to Assure Safe Use ("ETASU"); or (2) in the alternative, at a minimum, refrain from taking any action that would further reduce patient access to mifepristone and/or increase the burdens associated with prescribing or dispensing mifepristone. The Emergency Medicine Residents’ Association (“EMRA”) is the oldest and largest independent EM resident organization in the world. Founded in 1974, EMRA currently has more than 19,000 emergency medicine resident, fellow, medical student, and alumni members. EMRA is the voice of emergency medicine physicians-in-training and the future of our specialty. We are committed to advancing emergency medicine and protecting our patients through our core pillars: Education, Leadership, and Advocacy. EMRA writes to fully support and join the comments submitted by the FemInEM Foundation on July 1, 2026 under Tracking Numbers FDA-2025-P-0377-0257; FDA-2025-P-1576-0178; and FDA-2025-P-2162-0132. Respectfully submitted, Emergency Medicine Residents’ Association 1601 Utica Avenue South Minneapolis, Minnesota 55416 United States